commencement of phase 3 trials, page-7

G'day chris,

I really don't think what they 'want' has any bearing on the reality of how ACL is viewed; as a serious investment or someone's twisted idea of a joke.

If as you say; they are ultra conservative, why did they hand over-subscriptions back, in 2009?

I don't think they would really dare to add another (pointless) delay now.

RBS obviously doesn't see any risk in waiting for revenues; their previous (higher) target was based on raising only $9m in the CR.

If the 2nd tranche gets through, Orbis and co will look after their mates, so there will be no chance of getting rid of them.

I shouldn't be shocked but I am.